 | ||
| Campobasso - foto Gianni Lannes |
di Gianni Lannes
I
velivoli che a bassa e bassissima quota ricoprono di caliginose scie e
striature il territorio italiano cosa scaricano nell'aria con il beneplacito delle autorità italiane?
Si tratta di un progetto concreto già realizzato dall'OMS (WHO)? Oltre al litio psicotropo sversato nella ionosfera dalla NASA, altri hanno provato la somministrazione di vaccini via aerosol - l’irrorazione di vaccini per via aerea sulle popolazioni a loro insaputa e senza la loro autorizzazione - come riporta questo abstract scientifico su Pubmed. Diverse migliaia di persone sono state vaccinate tramite aerosol “per molti anni” in Russia - ma non solo - con “ceppi vivi attenuati contro molte malattie.” Inoltre, sono state condotte vaste sperimentazioni sul campo in Sudamerica usando il vaccino vivo attenuato del morbillo, definite molto positive. Buoni risultati sono stati riportati anche utilizzando un aerosol per vaccinare contro l’influenza A.
Si tratta di un progetto concreto già realizzato dall'OMS (WHO)? Oltre al litio psicotropo sversato nella ionosfera dalla NASA, altri hanno provato la somministrazione di vaccini via aerosol - l’irrorazione di vaccini per via aerea sulle popolazioni a loro insaputa e senza la loro autorizzazione - come riporta questo abstract scientifico su Pubmed. Diverse migliaia di persone sono state vaccinate tramite aerosol “per molti anni” in Russia - ma non solo - con “ceppi vivi attenuati contro molte malattie.” Inoltre, sono state condotte vaste sperimentazioni sul campo in Sudamerica usando il vaccino vivo attenuato del morbillo, definite molto positive. Buoni risultati sono stati riportati anche utilizzando un aerosol per vaccinare contro l’influenza A.
«L’introduzione del vaccino per via aerea, che ripercorre meglio la via naturale di molte infezioni, potrebbe portare allo sviluppo dell’immunità al portale d’ingresso, e potrebbe anche indurre una difesa più generalizzata,” sostengono i ricercatori.
Lo studio ha anche rilevato che il metodo ottimale di
vaccinazione per aerosol è attraverso il naso, che è considerato migliore per
le popolazioni pediatrica e geriatrica.
«In conclusione possiamo affermare che l’immunizzazione
tramite aerosol appare un metodo di vaccinazione promettente» concludono gli
autori dello studio.
riferimenti:
https://www.ncbi.nlm.nih.gov/pubmed/12656420
http://www.who.int/immunization/sage/meetings/2012/november/3_MeaslesAerosolVaccineProject-report_SAGE.pdf
https://academic.oup.com/trstmh/article/109/3/175/1891548
https://watermark.silverchair.com/milmed-161-5-251.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAkAwggI8BgkqhkiG9w0BBwagggItMIICKQIBADCCAiIGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQM_3KtMc2SrdcxwJL8AgEQgIIB82iOpXLoSPuxWhGAAGCxUARwQng80cX7-ufK_31_gUhACp-2FkFy3EJ1r4jp9nNQgwTDoU2w6VUIGqxCueiGCecOgIP5_XykvOFQERiDzikkLVBxE4RzckYmw2Nl4tUMBMbELM8SR6EnHEk67EHsga2PQE3W7nBYCaElhRh-XWbIb32aMGxWk0RoEiKfs5yRxydXzG_E24rgtle80GphwsYwCChyfUabkYmfqcMLEKLmf0N1oUnecVxUX1n_rTm5l9TtI43PjuF1CqhfhclUpA6pVRF-kyGSrt4dugJO0NXw9KQo_kHYV6GYt7dUd4ufShgEZyOyOgUXMxP90sH4Q5Gonzv8pis5vG4LwwqVGzfMG9HslcHcJckg8Imz7Qfe9pDSvEGdsjBuAaX7NInZ84XJ7ZPRg-EvUxBqJU37_lXRMl9jvXyYX9oIfT0w9i6MWYhBi2JYZJ4-uDcLseQGtL_vIfjfR7cTYejDwHOFz0uubTFNbxOve9dQs_lw4JSOeRJVQL0ZO6ZOnlm0nacoxBlbZvKsB9FTiXd7lKrTZdgZaIWhuuc4axIfwQHZKfRuyQzcp_NS2WRHj3OPwixI9oOJOOvxUi9QGVhrtXOlnbOlqTKlGplpk69JOqW2k1xId-YWpAoooFLf-v1DcIereHpZ3RY
https://www.airuniversity.af.edu/Portals/10/CSAT/documents/researchpapers/2007/bh2007_csat61.pdf
https://www.airuniversity.af.edu/CSAT/
https://www.ncbi.nlm.nih.gov/pubmed/8855053
https://www.medscape.com/viewarticle/452339
https://www.liebertpub.com/doi/abs/10.1089/15387130360514814?journalCode=bsp
https://www.sciencedirect.com/science/article/pii/S1198743X14641732
https://www.sciencedirect.com/science/article/pii/S1198743X14641744
http://www.cs.amedd.army.mil/borden/
https://usiraq.procon.org/sourcefiles/CRS_2-20-08.pdf
https://www.princeton.edu/~ota/disk1/1993/9341/9341.PDF
https://archive.nytimes.com/www.nytimes.com/books/first/e/endicott-biological.html
https://rockymountainarsenalarchive.files.wordpress.com/2011/07/ja_112.pdf
http://news.bbc.co.uk/2/hi/programmes/file_on_4/4701196.stm
Arnon, S.A., et al. Botulinum as a biological weapon: Medical and public health management. JAMA 2001;285(8):1059-1070. Accessed 01/10/2018.
BARDA Strategic Plan. (337 KB). Accessed 01/10/2018.
Ben Ouagrham, S. Biological weapons threats from the former Soviet Union. Working Paper Series on Russia and the Former Soviet States. Liechtenstein Institute on Self-Determination at Princeton University. August 2003.
Department of Health and Human Services. Challenges in the use of anthrax vaccine adsorbed (AVA) in the pediatric population as a component of post-exposure prophylaxis (PEP): A Report of the National Biodefense Science Board. [PDF File]. October 2011. (1.3 MB). Retrieved from Homeland Security Digital Library. Accessed 01/10/2018.
Fenn, E.A. Biological Warfare in eighteenth-century North America: beyond Jeffery Amherst. Politics and the Life Sciences. Accessed 01/10/2018.
Henderson, D.A., Inglesby, T.V., Jr. O’Toole, T., Mortimer, P.P. Can postexposure vaccination against smallpox succeed? Clin In Dis. (2003) 36 (5); 622-629. Accessed 01/10/2018.
Global Trends 2030: Alternative Worlds. A publication of the National Intelligence Council. December 2012. (20.5 MB). Accessed 01/10/2018.
Martin, J.W., Christropher, G.W., Eitzen, E.M., Jr. History of biological weapons: from poisoned darts to intentional epidemics. [PDF]. Medical Aspects of Biological Warfare. Accessed 01/10/2018.
McConnell, M. Remarks and Q&A by the Director of National Intelligence. December 2, 2008. (111 KB). Accessed 01/10/2018.
McIsaac, J.H. Preparing hospitals for bioterror: a medical and biomedical systems approach. Burlington, Mass.: Academic Press, 2006.
Center for Law and Public Health. Model State Emergency Health Powers Act. A Draft for Discussion Prepared by The Center for Law and the Public’s Health at Georgetown and Johns Hopkins Universities. (88.8 KB). Accessed 01/10/2018.
Nightingale, S.L., Prasher, J.M., Simonson, S. Emergency Use Authorization (EUA) to enable use of needed products in civilian and military emergencies, United States. Emerg Infect Dis [serial on the Internet]. 2007 Jul. Accessed 01/10/2018.
O’Tool, T., Michael, M., Inglesby, T.V. Shining light on "Dark Winter." CID 34:7, 972-983. Accessed 01/10/2018.
Quinn, S.C., Thomas, T., Kumar, K. The anthrax vaccine and research: reactions from postal workers and public health professionals. Biosecur Bioterror. 2008 December; 6(4): 321–333. Accessed 01/10/2018.
Southern Illinois University School of Medicine. Overview of potential agents of biological terrorism. Accessed 01/10/2018.
Stein, R. Possible study of anthrax vaccine’s effectiveness in children stirs debate. Washington Post, 10/13/11. Accessed 01/10/2018.
Tucker, J.B. Scourge: the once and future threat of smallpox. New York: Grove Press, 1992.
Wheelis, M. Biological warfare at the 1346 siege of Caffa. Emerg Infect Dis [serial online] 2002 Sep. Accessed 01/10/2018.
Wilkening, D.A. Sverdlovsk revisited: Modeling human inhalation anthrax. PNAS 103;20:7589-7594. Accessed 01/10/2018.
http://www.who.int/immunization/sage/meetings/2012/november/3_MeaslesAerosolVaccineProject-report_SAGE.pdf
https://academic.oup.com/trstmh/article/109/3/175/1891548
https://watermark.silverchair.com/milmed-161-5-251.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAkAwggI8BgkqhkiG9w0BBwagggItMIICKQIBADCCAiIGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQM_3KtMc2SrdcxwJL8AgEQgIIB82iOpXLoSPuxWhGAAGCxUARwQng80cX7-ufK_31_gUhACp-2FkFy3EJ1r4jp9nNQgwTDoU2w6VUIGqxCueiGCecOgIP5_XykvOFQERiDzikkLVBxE4RzckYmw2Nl4tUMBMbELM8SR6EnHEk67EHsga2PQE3W7nBYCaElhRh-XWbIb32aMGxWk0RoEiKfs5yRxydXzG_E24rgtle80GphwsYwCChyfUabkYmfqcMLEKLmf0N1oUnecVxUX1n_rTm5l9TtI43PjuF1CqhfhclUpA6pVRF-kyGSrt4dugJO0NXw9KQo_kHYV6GYt7dUd4ufShgEZyOyOgUXMxP90sH4Q5Gonzv8pis5vG4LwwqVGzfMG9HslcHcJckg8Imz7Qfe9pDSvEGdsjBuAaX7NInZ84XJ7ZPRg-EvUxBqJU37_lXRMl9jvXyYX9oIfT0w9i6MWYhBi2JYZJ4-uDcLseQGtL_vIfjfR7cTYejDwHOFz0uubTFNbxOve9dQs_lw4JSOeRJVQL0ZO6ZOnlm0nacoxBlbZvKsB9FTiXd7lKrTZdgZaIWhuuc4axIfwQHZKfRuyQzcp_NS2WRHj3OPwixI9oOJOOvxUi9QGVhrtXOlnbOlqTKlGplpk69JOqW2k1xId-YWpAoooFLf-v1DcIereHpZ3RY
https://www.airuniversity.af.edu/Portals/10/CSAT/documents/researchpapers/2007/bh2007_csat61.pdf
https://www.airuniversity.af.edu/CSAT/
https://www.ncbi.nlm.nih.gov/pubmed/8855053
https://www.medscape.com/viewarticle/452339
https://www.liebertpub.com/doi/abs/10.1089/15387130360514814?journalCode=bsp
https://www.sciencedirect.com/science/article/pii/S1198743X14641732
https://www.sciencedirect.com/science/article/pii/S1198743X14641744
http://www.cs.amedd.army.mil/borden/
https://usiraq.procon.org/sourcefiles/CRS_2-20-08.pdf
https://www.princeton.edu/~ota/disk1/1993/9341/9341.PDF
https://archive.nytimes.com/www.nytimes.com/books/first/e/endicott-biological.html
https://rockymountainarsenalarchive.files.wordpress.com/2011/07/ja_112.pdf
http://news.bbc.co.uk/2/hi/programmes/file_on_4/4701196.stm
Arnon, S.A., et al. Botulinum as a biological weapon: Medical and public health management. JAMA 2001;285(8):1059-1070. Accessed 01/10/2018.
BARDA Strategic Plan. (337 KB). Accessed 01/10/2018.
Ben Ouagrham, S. Biological weapons threats from the former Soviet Union. Working Paper Series on Russia and the Former Soviet States. Liechtenstein Institute on Self-Determination at Princeton University. August 2003.
Department of Health and Human Services. Challenges in the use of anthrax vaccine adsorbed (AVA) in the pediatric population as a component of post-exposure prophylaxis (PEP): A Report of the National Biodefense Science Board. [PDF File]. October 2011. (1.3 MB). Retrieved from Homeland Security Digital Library. Accessed 01/10/2018.
Fenn, E.A. Biological Warfare in eighteenth-century North America: beyond Jeffery Amherst. Politics and the Life Sciences. Accessed 01/10/2018.
Henderson, D.A., Inglesby, T.V., Jr. O’Toole, T., Mortimer, P.P. Can postexposure vaccination against smallpox succeed? Clin In Dis. (2003) 36 (5); 622-629. Accessed 01/10/2018.
Global Trends 2030: Alternative Worlds. A publication of the National Intelligence Council. December 2012. (20.5 MB). Accessed 01/10/2018.
Martin, J.W., Christropher, G.W., Eitzen, E.M., Jr. History of biological weapons: from poisoned darts to intentional epidemics. [PDF]. Medical Aspects of Biological Warfare. Accessed 01/10/2018.
McConnell, M. Remarks and Q&A by the Director of National Intelligence. December 2, 2008. (111 KB). Accessed 01/10/2018.
McIsaac, J.H. Preparing hospitals for bioterror: a medical and biomedical systems approach. Burlington, Mass.: Academic Press, 2006.
Center for Law and Public Health. Model State Emergency Health Powers Act. A Draft for Discussion Prepared by The Center for Law and the Public’s Health at Georgetown and Johns Hopkins Universities. (88.8 KB). Accessed 01/10/2018.
Nightingale, S.L., Prasher, J.M., Simonson, S. Emergency Use Authorization (EUA) to enable use of needed products in civilian and military emergencies, United States. Emerg Infect Dis [serial on the Internet]. 2007 Jul. Accessed 01/10/2018.
O’Tool, T., Michael, M., Inglesby, T.V. Shining light on "Dark Winter." CID 34:7, 972-983. Accessed 01/10/2018.
Quinn, S.C., Thomas, T., Kumar, K. The anthrax vaccine and research: reactions from postal workers and public health professionals. Biosecur Bioterror. 2008 December; 6(4): 321–333. Accessed 01/10/2018.
Southern Illinois University School of Medicine. Overview of potential agents of biological terrorism. Accessed 01/10/2018.
Stein, R. Possible study of anthrax vaccine’s effectiveness in children stirs debate. Washington Post, 10/13/11. Accessed 01/10/2018.
Tucker, J.B. Scourge: the once and future threat of smallpox. New York: Grove Press, 1992.
Wheelis, M. Biological warfare at the 1346 siege of Caffa. Emerg Infect Dis [serial online] 2002 Sep. Accessed 01/10/2018.
Wilkening, D.A. Sverdlovsk revisited: Modeling human inhalation anthrax. PNAS 103;20:7589-7594. Accessed 01/10/2018.
